See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 7, 2002

Sepsis and Septicemia Depression (Treatment-Resistant) Diabetic Neuropathy

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.

Sepsis and Septicemia

Research study to evaluate the efficacy and safety of Drotrecogin Alfa (Activated) in adult patients with Early Stage Severe Sepsis. To be included in this study you must: be an adult with severe sepsis, have presence of a suspected or proven infection and one or more instances of sepsis-associated organ failure. Sites throughout the world.

More Information

Please see http://www.centerwatch.com/patient/studies/cat139.html.

-----

Depression (Treatment-Resistant)

A research study to evaluate the efficacy and safety of an investigational drug in patients 18 to 85 years old with treatment-resistant depression. Sites throughout the USA.

More Information

Please see http://www.centerwatch.com/patient/studies/cat46.html.

-----

Diabetic Neuropathy

Clinical trial for the treatment for Symptomatic Peripheral Neuropathy in patients with diabetes. The purpose of this study is to determine if an investigational drug is effective in treating nerve malfunction in diabetes. Sites throughout the world.

More Information

Please see http://www.centerwatch.com/patient/studies/cat253.html.

-----

Copyright 2002 Centerwatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.